微信内可能无法直接打开本站。请点右上角 ··· → 在浏览器打开，或复制链接后用系统浏览器访问。
XMT
信流 · 上滑连读 · 来源可核
STAT+: Can a pregnancy hormone steer a cardiovascular treatment?
Want to stay on top of the science and politics driving biotech today?Sign up to get our biotech newsletter in your inbox.…
- Radiopharma researchers are pushing bolder dosing, cancer vaccines cou…
- It’s hot here.
- Continue to STAT+ to read the full story…
RSS 官方收录 · 可信分层展示
STAT+: We’re reading about drug pricing deals, a new cancer therapy approval, and more
Good morning and greetings from Pharmalot’s New York bureau.Jason Mast here filling in.…
- Today, I’m still listening to the music recommendation from Pharmalitt…
- Here’s today news: Bayer, Takeda, and CSL Behring — alongside several …
- The agreements are the latest in a slate of deals the Trump administra…
RSS 官方收录 · 可信分层展示
STAT+: Cadre of radiopharmaceuticals experts pushes the bounds in cancer therapy
Louise Emmett wants radiopharmaceutical developers to be bolder.Radiopharmaceuticals are a powerful new tool in oncology.…
- She and other experts believe that these 21st-century spins on radiati…
- But Emmett, who is a leader in the field and works with global drugmak…
- More specifically, she and likeminded experts believe the treatments c…
RSS 官方收录 · 可信分层展示
STAT+: After a rough stretch, mRNA gets a boost — at least for now
The mRNA technology that built Moderna and BioNTech’s Covid-19 vaccines and is now being used to build cancer vaccines has been through political whiplash.…
- But now, with clinical success from Moderna and Merck on using a perso…
- “I don’t know how this will be received among parts of our society tha…
- ’ There’s a possibility that people will say, ‘Oh, if we can vaccinate…
RSS 官方收录 · 可信分层展示
Opinion: The most shocking thing about the latest statistics on CTE in football is that we find them so shocking
A new study led by Boston-area researchers has set my media feeds abuzz with the finding that nearly 1 in 4 NFL players in their sample had CTE at time of death.…
- CTE, or chronic traumatic encephalopathy, is a degenerative brain dise…
- It is caused by repeated concussions and smaller non-concussive hits.
- As shocking as the 25% statistic is to many, the authors have suggeste…
RSS 官方收录 · 可信分层展示
STAT+: FDA approves Protagonist and Takeda’s drug for rare blood cancer
The Food and Drug Administration on Friday approved a new treatment for a rare and slow-growing cancer that causes an overproduction of red blood cells.…
- The drug, called rusfertide, was developed by the biotech company Prot…
- It will be sold by Takeda, the Japanese pharma company, under the bran…
- Administered via a weekly injection, Mimrylo was cleared to treat poly…
RSS 官方收录 · 可信分层展示
STAT+: Alnylam defends heart disease drugs after failure of AstraZeneca’s Wainua
When AstraZeneca on Friday detailed the failed trial of its drug Wainua in a heart condition known as ATTR-CM, the bad news, according to one school of thought, extended to Alnylam Pharmaceuticals.…
- Some analysts interpreted the study’s miss as a broad sign that silenc…
- Now, Alnylam is mounting a defense of its silencers, with ramification…
- Continue to STAT+ to read the full story…
RSS 官方收录 · 可信分层展示
STAT+: A Novartis drug cut inflammation. Can it improve heart outcomes?
A newly acquired Novartis drug successfully lowered signs of inflammation in a midstage study, as experts wait to hear how the company plans to advance the drug as a potential cardiovascular treatment.…
- In the Phase 2 TRANQUILITY study, the drug, pacibekitug, led to sustai…
- Investigators reported a dose-dependent drop in biomarker levels on ce…
- Pacibekitug is an antibody that targets IL-6, or interleukin-6, a prot…
RSS 官方收录 · 可信分层展示
Juul gets OK to sell updated vaping device with age-gating technology
WASHINGTON — Vaping company Juul Labs on Friday received federal permission to sell an updated version of its e-cigarette, which includes an optional age-verification system designed to prevent underage use.…
- The decision from the Food and Drug Administration allows the company …
- In recent years, the company has had to lay off hundreds of employees …
- Read the rest…
RSS 官方收录 · 可信分层展示
Opinion: The unintended consequences of the Lindsay Clancy case
Much of the focus on the Lindsay Clancy case has been on the reported systemic failures of the mental health system, with the hope that this case will revamp the approach to maternal mental health.…
- We, as forensic and reproductive psychiatrists, agree that the system …
- But we are concerned that this focus could have a dangerous unintended…
- In an ideal world, all mothers would have easy access to reproductive …
RSS 官方收录 · 可信分层展示
STAT+: Up and down the ladder: The latest comings and goings
Hired someone new and exciting?Promoted a rising star?Finally solved that hard-to-fill spot?…
- Share the news with us, and we’ll share it with others.
- That’s right.
- Send us your changes, and we’ll find a home for them.
RSS 官方收录 · 可信分层展示
STAT+: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching
Want to stay on top of the science and politics driving biotech today?Sign up to get our biotech newsletter in your inbox.…
- We have some news out of a meeting of the European Society of Cardiolo…
- RIP to Yayoi Kusama.
- Wearing manic polka dots today in tribute.
RSS 官方收录 · 可信分层展示
STAT+: Pharmalittle: We’re reading about an AstraZeneca trial failure, a ‘monstrous’ conflict of interest, and more
And so, another working week will soon come to a close.Not a moment too soon, yes?This is, you may recall, our treasured signal to daydream about weekend plans.…
- Our agenda is still taking shape, but we plan on promenading with the …
- Pharmalot to a speakeasy and, if time permits, holding another listeni…
- And what about you?
RSS 官方收录 · 可信分层展示
STAT+: Cytokinetics details trial win for what could be its next approval
It took Cytokinetics 27 years to win its first regulatory approval.The second one could happen much faster than that.…
- The biotech on Friday unveiled the full pivotal study data of its drug…
- While some experts have described the benefits as limited, Cytokinetic…
- If approved, it would be the first treatment specifically cleared for …
RSS 官方收录 · 可信分层展示
STAT+: In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs
AstraZeneca on Friday detailed the surprise failure of a closely watched heart disease clinical trial, laying out how its experimental drug offered no additional benefits for patients who were largely already on another type of medicine — the latest twist in a multi-billion dollar market.…
- The study indicated that patients with a progressive condition known a…
- Most participants were on a stabilizer at the outset of the trial.
- The trial’s miss has had implications not just for AstraZeneca and its…
RSS 官方收录 · 可信分层展示
Opinion: We quit the CDC last year. The problems we protested remain
One year ago, we jointly submitted our resignations from the Centers for Disease Control and Prevention.…
- Each of us had been tested as we tried to protect our communities and …
- But the political interference and scientific integrity issues we warn…
- They exposed vulnerabilities that still exist, and will remain after t…
RSS 官方收录 · 可信分层展示
STAT+: Vaccines take center stage at federal autism advisory committee
Vaccines took center stage at the federal autism advisory committee meeting Thursday, as committee members explicitly pointed to vaccines as a potential cause of autism, even though the link has been routinely debunked.…
- “We don’t want to close the door for any potential trigger, and that w…
- “We are quite open to investigating anything and everything.
- This plan closes no door.
RSS 官方收录 · 可信分层展示
Opinion: A billing code was supposed to incentivize relationship-based primary care for Medicare patients. It may not be working as hoped
Beatrice (not her real name) is here to see me after her fall, but our visit doesn’t end there.…
- I watch the security footage of the fall on her phone, check her head …
- And then I tackle her renewed anxiety, adjust her thyroid medication, …
- This is what it’s always meant to be a primary care doctor.
RSS 官方收录 · 可信分层展示
STAT+: FDA approves Roivant therapy for rare autoimmune disease
The Food and Drug Administration on Thursday approved a new medicine from Roivant and its subsidiary Priovant for the treatment of dermatomyositis, a rare autoimmune disease characterized by muscle weakness and a painful skin rash.…
- The drug, called brepocitinib, will be marketed under the brand name L…
- It’s a pill taken once daily.
- High doses of steroids and other immune-suppressing drugs are the curr…
RSS 官方收录 · 可信分层展示
STAT+: Hospitals plot their response to funding cuts
You’re reading the web edition of D.C.Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.…
- Sign up here to receive it in your inbox on Tuesdays and Thursdays.
- Joe Rogan and podcast guest Shane Gillis criticized Republicans for la…
- Send news tips and political signs of the times to John.
RSS 官方收录 · 可信分层展示
STAT+: CMS plans launch event for ACCESS, the Medicare chronic care pilot
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.…
- Sign up to get it delivered in your inbox every Tuesday and Thursday.
- Good morning health tech readers!
- Let’s talk about what’s happening in September.
RSS 官方收录 · 可信分层展示